These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 15863809)

  • 1. Substance abuse in first-episode bipolar I disorder: indications for early intervention.
    Baethge C; Baldessarini RJ; Khalsa HM; Hennen J; Salvatore P; Tohen M
    Am J Psychiatry; 2005 May; 162(5):1008-10. PubMed ID: 15863809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychiatric and medical comorbidities of bipolar disorder.
    Krishnan KR
    Psychosom Med; 2005; 67(1):1-8. PubMed ID: 15673617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obsessive-compulsive disorder in bipolar disorder patients with first manic episode.
    Pashinian A; Faragian S; Levi A; Yeghiyan M; Gasparyan K; Weizman R; Weizman A; Fuchs C; Poyurovsky M
    J Affect Disord; 2006 Aug; 94(1-3):151-6. PubMed ID: 16753221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxiety disorders among patients with co-occurring bipolar and substance use disorders.
    Kolodziej ME; Griffin ML; Najavits LM; Otto MW; Greenfield SF; Weiss RD
    Drug Alcohol Depend; 2005 Nov; 80(2):251-7. PubMed ID: 15876498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
    Simon NM; Otto MW; Wisniewski SR; Fossey M; Sagduyu K; Frank E; Sachs GS; Nierenberg AA; Thase ME; Pollack MH
    Am J Psychiatry; 2004 Dec; 161(12):2222-9. PubMed ID: 15569893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
    Lee JH; Dunner DL
    Depress Anxiety; 2008; 25(2):91-7. PubMed ID: 17311265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlates of 1-year prospective outcome in bipolar disorder: results from the Stanley Foundation Bipolar Network.
    Nolen WA; Luckenbaugh DA; Altshuler LL; Suppes T; McElroy SL; Frye MA; Kupka RW; Keck PE; Leverich GS; Post RM
    Am J Psychiatry; 2004 Aug; 161(8):1447-54. PubMed ID: 15285972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spectrum of substance abuse in bipolar disorder: reasons for use, sensation seeking and substance sensitivity.
    Bizzarri JV; Sbrana A; Rucci P; Ravani L; Massei GJ; Gonnelli C; Spagnolli S; Doria MR; Raimondi F; Endicott J; Dell'Osso L; Cassano GB
    Bipolar Disord; 2007 May; 9(3):213-20. PubMed ID: 17430295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder.
    McElroy SL; Altshuler LL; Suppes T; Keck PE; Frye MA; Denicoff KD; Nolen WA; Kupka RW; Leverich GS; Rochussen JR; Rush AJ; Post RM
    Am J Psychiatry; 2001 Mar; 158(3):420-6. PubMed ID: 11229983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Noordsy DL; Xie H; Drake RE
    Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Course of psychiatric and substance abuse syndromes co-occurring with bipolar disorder after a first psychiatric hospitalization.
    Strakowski SM; Sax KW; McElroy SL; Keck PE; Hawkins JM; West SA
    J Clin Psychiatry; 1998 Sep; 59(9):465-71. PubMed ID: 9771817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of rapid-cycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients.
    Kupka RW; Luckenbaugh DA; Post RM; Suppes T; Altshuler LL; Keck PE; Frye MA; Denicoff KD; Grunze H; Leverich GS; McElroy SL; Walden J; Nolen WA
    Am J Psychiatry; 2005 Jul; 162(7):1273-80. PubMed ID: 15994709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bipolar obsessive-compulsive disorder and personality disorders.
    Maina G; Albert U; Pessina E; Bogetto F
    Bipolar Disord; 2007 Nov; 9(7):722-9. PubMed ID: 17988362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and distinct correlates of anxiety, substance, and combined comorbidity in a multi-site public sector sample with bipolar disorder.
    Bauer MS; Altshuler L; Evans DR; Beresford T; Williford WO; Hauger R;
    J Affect Disord; 2005 Apr; 85(3):301-15. PubMed ID: 15780700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical particularism of bipolar disorder: unipolar mania. About a patient's study in Tunesia].
    Dakhlaoui O; Essafi I; Haffani F
    Encephale; 2008 Sep; 34(4):337-42. PubMed ID: 18922234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manic symptoms and impulsivity during bipolar depressive episodes.
    Swann AC; Moeller FG; Steinberg JL; Schneider L; Barratt ES; Dougherty DM
    Bipolar Disord; 2007 May; 9(3):206-12. PubMed ID: 17430294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of substance use and psychiatric disorders in a highly select chronic pain population.
    Proctor SL; Estroff TW; Empting LD; Shearer-Williams S; Hoffmann NG
    J Addict Med; 2013; 7(1):17-24. PubMed ID: 23131838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV.
    Hasin D; Samet S; Nunes E; Meydan J; Matseoane K; Waxman R
    Am J Psychiatry; 2006 Apr; 163(4):689-96. PubMed ID: 16585445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].
    Verdoux H; Mury M; Besançon G; Bourgeois M
    Encephale; 1996; 22(2):95-101. PubMed ID: 8706627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD).
    Perlis RH; Miyahara S; Marangell LB; Wisniewski SR; Ostacher M; DelBello MP; Bowden CL; Sachs GS; Nierenberg AA;
    Biol Psychiatry; 2004 May; 55(9):875-81. PubMed ID: 15110730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.